These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 17600172)

  • 1. Creatine kinase elevation associated with bipolar disorder and ephedrine abuse.
    Borgerding LA; Lineberry TW; Bostwick JM
    Psychosomatics; 2007; 48(4):348-9. PubMed ID: 17600172
    [No Abstract]   [Full Text] [Related]  

  • 2. Specificity of bipolar spectrum conditions in the comorbidity of mood and substance use disorders: results from the Zurich cohort study.
    Merikangas KR; Herrell R; Swendsen J; Rössler W; Ajdacic-Gross V; Angst J
    Arch Gen Psychiatry; 2008 Jan; 65(1):47-52. PubMed ID: 18180428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The specific burden of comorbid anxiety disorders and of substance use disorders in bipolar I disorder.
    Goldstein BI; Levitt AJ
    Bipolar Disord; 2008 Feb; 10(1):67-78. PubMed ID: 18199243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comorbid addictions in bipolar disorder].
    Gorwood P; LeStrat Y; Wohl M
    Encephale; 2008 Jun; 34 Suppl 4():S138-42. PubMed ID: 18707936
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical particularism of bipolar disorder: unipolar mania. About a patient's study in Tunesia].
    Dakhlaoui O; Essafi I; Haffani F
    Encephale; 2008 Sep; 34(4):337-42. PubMed ID: 18922234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in prevalence and patterns of substance use in schizophrenia and bipolar disorder.
    Ringen PA; Lagerberg TV; Birkenaes AB; Engn J; Faerden A; Jónsdottir H; Nesvåg R; Friis S; Opjordsmoen S; Larsen F; Melle I; Andreassen OA
    Psychol Med; 2008 Sep; 38(9):1241-9. PubMed ID: 18070373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of co-morbid alcohol use disorder in bipolar patients.
    Cardoso BM; Kauer Sant'Anna M; Dias VV; Andreazza AC; Ceresér KM; Kapczinski F
    Alcohol; 2008 Sep; 42(6):451-7. PubMed ID: 18760714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Youth substance use and abuse: challenges and strategies for identification and intervention.
    Leslie K
    CMAJ; 2008 Jan; 178(2):145-8. PubMed ID: 18195284
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis C testing and infection rates in bipolar patients with and without comorbid substance use disorders.
    Matthews AM; Huckans MS; Blackwell AD; Hauser P
    Bipolar Disord; 2008 Mar; 10(2):266-70. PubMed ID: 18271905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CK levels in unmedicated bipolar patients.
    Segal M; Avital A; Drobot M; Lukanin A; Derevenski A; Sandbank S; Weizman A
    Eur Neuropsychopharmacol; 2007 Dec; 17(12):763-7. PubMed ID: 17628446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug screening: adjunct to the differential diagnosis of drug intoxication.
    Cherkes JK
    Med Health R I; 2006 Nov; 89(11):377-8. PubMed ID: 17168088
    [No Abstract]   [Full Text] [Related]  

  • 12. Reliability of the Mood Disorder Questionnaire: comparison with the Structured Clinical Interview for the DSM-IV-TR in a population sample.
    Dodd S; Williams LJ; Jacka FN; Pasco JA; Bjerkeset O; Berk M
    Aust N Z J Psychiatry; 2009 Jun; 43(6):526-30. PubMed ID: 19440884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up.
    Mazza M; Mandelli L; Di Nicola M; Harnic D; Catalano V; Tedeschi D; Martinotti G; Colombo R; Bria P; Serretti A; Janiri L
    J Affect Disord; 2009 May; 115(1-2):27-35. PubMed ID: 18845344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the ICD-10 diagnostic subtype of depression in bipolar disorder compared to recurrent depressive disorder.
    Kessing LV; Jensen HM; Christensen EM
    Psychopathology; 2008; 41(3):141-6. PubMed ID: 18187963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening and semiquantitative analysis of drugs and drugs of abuse in human serum samples using gas chromatography-mass spectrometry.
    Maresova V; Chadt J; Novakova E
    Neuro Endocrinol Lett; 2008 Oct; 29(5):749-54. PubMed ID: 18987582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Predictors of prophylactic response to lithium].
    Rohayem J; Baylé JF; Richa S
    Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No evidence for physical anhedonia as a candidate symptom or an endophenotype in bipolar affective disorder.
    Etain B; Roy I; Henry C; Rousseva A; Schürhoff F; Leboyer M; Bellivier F
    Bipolar Disord; 2007 Nov; 9(7):706-12. PubMed ID: 17988360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residual symptom recovery from major affective episodes in bipolar disorders and rapid episode relapse/recurrence.
    Judd LL; Schettler PJ; Akiskal HS; Coryell W; Leon AC; Maser JD; Solomon DA
    Arch Gen Psychiatry; 2008 Apr; 65(4):386-94. PubMed ID: 18391127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid assessment methodology: its origins, development and use by the United Nations International Drug Control Programme.
    Bull Narc; 1996; 48(1-2):1-10. PubMed ID: 9839032
    [No Abstract]   [Full Text] [Related]  

  • 20. Bipolar obsessive-compulsive disorder and personality disorders.
    Maina G; Albert U; Pessina E; Bogetto F
    Bipolar Disord; 2007 Nov; 9(7):722-9. PubMed ID: 17988362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.